• KNUCKLES Integrates Auxin and Cytokinin to Terminate Floral

  2026-07-28

  This study uncovers how the transcriptional repressor KNUCKLES (KNU) coordinates the distribution of auxin and cytokinin to ensure timely floral meristem (FM) termination in Arabidopsis. By directly repressing key hormonal pathway genes, KNU secures proper floral organ development, refining our understanding of plant developmental timing mechanisms.

• Bacitracin (B1670): Technical Use and Protocol Guidance

  2026-07-27

  Bacitracin (B1670) is a peptide antibiotic used in laboratory workflows for disruption of bacterial cell wall and peptidoglycan synthesis, supporting antibacterial research on both gram-positive and gram-negative bacteria. It is intended strictly for controlled research settings and should not be used in diagnostic or medical applications.

• S63845: Precision MCL1 Inhibition for Apoptosis Research

  2026-07-27

  S63845 is a potent, selective small molecule MCL1 inhibitor that activates the mitochondrial apoptotic pathway in MCL1-dependent cancer cells. Its low nanomolar affinity and proven in vitro and in vivo efficacy establish it as a reference tool for hematological cancer research. Mechanistic and benchmark data underline its value for dissecting apoptosis resistance and workflow optimization.

• Direct Mouse Genotyping Kit Plus: Precision Genotyping for T

  2026-07-26

  Explore how the Direct Mouse Genotyping Kit Plus elevates mouse genotyping assays for translational atherosclerosis research. This article reveals advanced scientific rationale, new application depth, and practical protocols for leveraging this PCR master mix with dye reagents in disease modeling.

• Machine Learning-Driven LNPs for Microglial mRNA Immunomodul

  2026-07-25

  This study pioneers a machine learning-guided approach to optimize lipid nanoparticle (LNP) formulations for effective mRNA delivery targeting hyperactivated microglia. The findings reveal that rational LNP design, leveraging computational models, can modulate neuroinflammatory phenotypes—highlighting a path forward for mRNA-based therapies in neurodegenerative disease contexts.

• Selective PDGFR Inhibition Prevents Pulmonary Vascular Remod

  2026-07-24

  The referenced study introduces WQ-C-401, a highly selective PDGFR inhibitor, demonstrating its capacity to prevent pulmonary vascular remodeling in a rat model of monocrotaline-induced pulmonary arterial hypertension (PAH). These findings highlight the therapeutic potential of precise PDGFR targeting and provide a benchmark for optimizing tyrosine kinase inhibition strategies in vascular disease models.

• Dexamethasone (DHAP): Advanced Pathway Dissection in Tumor a

  2026-07-24

  Explore how Dexamethasone, a potent glucocorticoid anti-inflammatory, enables precise pathway interrogation in tumor biology and stem cell differentiation. This article uniquely bridges mutational landscape insights with practical assay optimization.

• Genistein (A2198): Benchmarks and Workflows for Cancer Resea

  2026-07-23

  Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) is a potent, selective protein tyrosine kinase inhibitor with validated efficacy in cell proliferation inhibition and cancer chemoprevention. Its mechanistic and quantitative profile enables reproducible dissection of oncogenic signaling and cytoskeleton-dependent pathways in vitro and in vivo. This article details evidence-based parameters, protocol integration, and key misconceptions for translational researchers.

• Halazone: Mechanistic Leverage for Translational Research

  2026-07-23

  Explore how Halazone advances both water disinfection and neurophysiological research through unique mechanistic actions, rigorous protocol parameters, and translational insights. This thought-leadership article bridges mechanistic understanding with strategic experimental guidance, delivering actionable intelligence for scientists seeking robust, multi-domain solutions.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Lab Work

  2026-07-22

  Chlorpromazine HCl enables precise dopamine receptor inhibition and robust blockade of clathrin-mediated endocytosis, making it essential for both neuropharmacology and infection cell biology research. This article details best-practice protocols, troubleshooting strategies, and translational insights to drive reproducible results in advanced experimental models.

• Vaccinia Virus F1L Inhibits ZAKα-Dependent NLRP1 Inflammasom

  2026-07-22

  This study reveals that the vaccinia virus protein F1L effectively blocks NLRP1 inflammasome activation in epithelial cells by inhibiting the ribotoxic stress response, specifically upstream of ZAKα signaling. These findings shed light on viral immune evasion strategies and provide a foundation for further research into host-pathogen interactions and inflammasome regulation.

• (S)-(+)-Methoprene: Applied Protocols for Juvenile Hormone R

  2026-07-21

  (S)-(+)-Methoprene stands out as a juvenile hormone analog, enabling precise dissection of hormone-regulated development and endocrine disruption in insects. This article delivers hands-on workflows, troubleshooting tips, and protocol enhancements for maximizing the impact of this compound in advanced research settings.

• Sequencing Therapies in Waldenström Macroglobulinemia: Insig

  2026-07-21

  This article analyzes a 2021 review on optimizing therapy sequencing in Waldenström macroglobulinemia (WM), emphasizing the pivotal role of genomic profiling, especially MYD88 and CXCR4 mutations, in guiding treatment selection. The findings highlight personalized approaches and discuss the evidence base for main therapeutic classes, offering a foundation for future research and clinical application.

• Nelfinavir Mesylate: Precision HIV-1 Protease Inhibitor Insi

  2026-07-20

  Nelfinavir Mesylate is a potent, orally bioavailable HIV-1 protease inhibitor with nanomolar efficacy, validated for HIV replication suppression and emerging as a tool in ferroptosis research. This article provides structured, evidence-based insights on its mechanisms, applications, and protocol parameters.

• Hoechst 33342 Nuclear Stain: Optimized Workflows & Applicati

  2026-07-20

  Hoechst 33342 Solution (1 mg/mL) enables crisp, low-toxicity nuclear staining for both live and fixed cell assays, supporting advanced workflows in fluorescence microscopy and flow cytometry. Discover practical protocol enhancements, troubleshooting strategies, and translational insights from recent dermal fibroblast aging research.

482 records 12/33 page Previous Next First page 上5页 1112131415 下5页 Last page